Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-DM1-related telangiectasias: a potential role in secondary bleeding events.
Sibaud V, Vigarios E, Combemale P, Lamant L, Lacouture ME, Lacaze JL, Dalenc F, Delord JP. Sibaud V, et al. Among authors: lacouture me. Ann Oncol. 2015 Feb;26(2):436-7. doi: 10.1093/annonc/mdu533. Epub 2014 Nov 17. Ann Oncol. 2015. PMID: 25403586 Free article. No abstract available.
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.
Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. Chan A, et al. Among authors: lacouture me. Support Care Cancer. 2015 Aug;23(8):2231-44. doi: 10.1007/s00520-014-2564-x. Epub 2015 Jan 7. Support Care Cancer. 2015. PMID: 25564221 Free PMC article. Review.
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.
Naidoo J, Page DB, Li BT, Connell LC, Schindler K, Lacouture ME, Postow MA, Wolchok JD. Naidoo J, et al. Among authors: lacouture me. Ann Oncol. 2015 Dec;26(12):2375-91. doi: 10.1093/annonc/mdv383. Epub 2015 Sep 14. Ann Oncol. 2015. PMID: 26371282 Free PMC article. Review.
Alopecia in patients treated with molecularly targeted anticancer therapies.
Belum VR, Marulanda K, Ensslin C, Gorcey L, Parikh T, Wu S, Busam KJ, Gerber PA, Lacouture ME. Belum VR, et al. Among authors: lacouture me. Ann Oncol. 2015 Dec;26(12):2496-502. doi: 10.1093/annonc/mdv390. Epub 2015 Sep 19. Ann Oncol. 2015. PMID: 26387145 Free PMC article.
Dermatological adverse events with taxane chemotherapy.
Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME. Sibaud V, et al. Among authors: lacouture me. Eur J Dermatol. 2016 Oct 1;26(5):427-443. doi: 10.1684/ejd.2016.2833. Eur J Dermatol. 2016. PMID: 27550571 Free PMC article. Review.
reply to the letter to the editor 'Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial' by Ceccarelli et al.
Lacouture ME; authors of the publication “A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer”. Lacouture ME, et al. Ann Oncol. 2016 Nov;27(11):2138-2139. doi: 10.1093/annonc/mdw403. Epub 2016 Sep 23. Ann Oncol. 2016. PMID: 27664149 Free PMC article. No abstract available.
324 results